+ Follow antidepressants Tag
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 1877320
[Title] => Hope is on the horizon for novel antidepressants
[Summary] => There remains a great unmet need for more effective and rapidly acting treatments for major depressive disorder, and research is revealing that both new and existing drugs may help, according to one expert.
[DatePublished] => 2018-12-16 00:00:00
[ColumnID] => 136231
[Focus] => 1
[AuthorID] => 1805110
[AuthorName] => Charles C. Chante MD
[SectionName] => Opinion
[SectionUrl] => opinion
[URL] =>
)
[1] => Array
(
[ArticleID] => 62817
[Title] => FDA calls for stronger antidepressant warning
[Summary] =>
[DatePublished] => 2008-05-18 00:00:00
[ColumnID] => 136231
[Focus] => 0
[AuthorID] => 1805110
[AuthorName] => Charles C. Chante MD
[SectionName] => Opinion
[SectionUrl] => opinion
[URL] =>
)
[2] => Array
(
[ArticleID] => 33664
[Title] => Antidepressants tied to suicide attempts only
[Summary] =>
[DatePublished] => 2007-12-16 00:00:00
[ColumnID] => 136231
[Focus] => 0
[AuthorID] => 1805110
[AuthorName] => Charles C. Chante MD
[SectionName] => Opinion
[SectionUrl] => opinion
[URL] =>
)
[3] => Array
(
[ArticleID] => 394542
[Title] => FDA scrutinizes antidepressants,risk of suicidality
[Summary] =>
Warning may be applied to young adults. Concerns about the risk of suicidality in patients on antidepressant therapy have deepened as a result of a Food and Drug Administration advisory panel’s recommendation to expand a black box warning to include young adults. The proposal also sparked concern, expressed by some of the panelists, that extension of the warning might discourage appropriate antidepressant prescribing.
[DatePublished] => 2007-04-15 00:00:00
[ColumnID] => 136231
[Focus] => 0
[AuthorID] => 1805110
[AuthorName] => Charles C. Chante MD
[SectionName] => Opinion
[SectionUrl] => opinion
[URL] =>
)
)
)
antidepressants
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 1877320
[Title] => Hope is on the horizon for novel antidepressants
[Summary] => There remains a great unmet need for more effective and rapidly acting treatments for major depressive disorder, and research is revealing that both new and existing drugs may help, according to one expert.
[DatePublished] => 2018-12-16 00:00:00
[ColumnID] => 136231
[Focus] => 1
[AuthorID] => 1805110
[AuthorName] => Charles C. Chante MD
[SectionName] => Opinion
[SectionUrl] => opinion
[URL] =>
)
[1] => Array
(
[ArticleID] => 62817
[Title] => FDA calls for stronger antidepressant warning
[Summary] =>
[DatePublished] => 2008-05-18 00:00:00
[ColumnID] => 136231
[Focus] => 0
[AuthorID] => 1805110
[AuthorName] => Charles C. Chante MD
[SectionName] => Opinion
[SectionUrl] => opinion
[URL] =>
)
[2] => Array
(
[ArticleID] => 33664
[Title] => Antidepressants tied to suicide attempts only
[Summary] =>
[DatePublished] => 2007-12-16 00:00:00
[ColumnID] => 136231
[Focus] => 0
[AuthorID] => 1805110
[AuthorName] => Charles C. Chante MD
[SectionName] => Opinion
[SectionUrl] => opinion
[URL] =>
)
[3] => Array
(
[ArticleID] => 394542
[Title] => FDA scrutinizes antidepressants,risk of suicidality
[Summary] =>
Warning may be applied to young adults. Concerns about the risk of suicidality in patients on antidepressant therapy have deepened as a result of a Food and Drug Administration advisory panel’s recommendation to expand a black box warning to include young adults. The proposal also sparked concern, expressed by some of the panelists, that extension of the warning might discourage appropriate antidepressant prescribing.
[DatePublished] => 2007-04-15 00:00:00
[ColumnID] => 136231
[Focus] => 0
[AuthorID] => 1805110
[AuthorName] => Charles C. Chante MD
[SectionName] => Opinion
[SectionUrl] => opinion
[URL] =>
)
)
)
abtest
